Literature DB >> 6217010

Cyclosporin A: a selective anti-T cell agent.

B D Kahan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6217010

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


× No keyword cloud information.
  6 in total

1.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

2.  Potentiation of vascular smooth muscle cell activity by cyclosporin A.

Authors:  R Locher; R Huss; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Lymphocyte subsets in patients with compositae oleoresin dermatitis and increased UVA sensitivity during treatment with azathioprine.

Authors:  O Baadsgaard; C Geisler; T Plesner; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Cyclosporin-A-induced hair growth in human renal allograft recipients and alopecia areata.

Authors:  W Gebhart; J B Schmidt; M Schemper; J Spona; H Kopsa; J Zazgornik
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.

Authors:  Wai-Lok Yau; Thierry Blisnick; Jean-François Taly; Manuela Helmer-Citterich; Cordelia Schiene-Fischer; Olivier Leclercq; Jing Li; Dirk Schmidt-Arras; Miguel A Morales; Cedric Notredame; Daniel Romo; Philippe Bastin; Gerald F Späth
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

6.  Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells.

Authors:  J Pfeilschifter; U T Rüegg
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.